CD95 stimulation results in the formation of a novel death effector domain protein-containing complex

J Biol Chem. 2008 Sep 26;283(39):26401-8. doi: 10.1074/jbc.M800823200. Epub 2008 Jul 17.

Abstract

Stimulation of CD95 (APO-1/Fas) by its natural ligand CD95L (APO-1L/FasL) leads to the formation of the death-inducing signaling complex. Here we report that upon CD95 stimulation in several T and B cell lines, a novel signaling complex is formed, which we term complex II. Complex II is composed of the death effector domain proteins as follows: procaspase-8a/b, three isoforms of c-FLIP (c-FLIP(L), c-FLIP(S), c-FLIP(R)), and FADD. Notably, complex II does not contain CD95. Based on our findings we suggest that CD95 signaling includes two steps. The first step involves formation of the death-inducing signaling complex at the cell membrane. The second step involves formation of the cytosolic death effector domain protein-containing complex that may play an important role in amplification of caspase activation.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animals
  • B-Lymphocytes / metabolism*
  • CASP8 and FADD-Like Apoptosis Regulating Protein / metabolism
  • Caspase 8 / metabolism
  • Cell Membrane / metabolism
  • Fas Ligand Protein / metabolism*
  • Fas Ligand Protein / pharmacology
  • Fas-Associated Death Domain Protein / metabolism
  • Humans
  • Jurkat Cells
  • Mice
  • Multiprotein Complexes / metabolism*
  • Protein Isoforms / metabolism
  • Protein Structure, Tertiary / physiology
  • Signal Transduction / drug effects
  • Signal Transduction / physiology*
  • T-Lymphocytes / metabolism*
  • fas Receptor / agonists
  • fas Receptor / metabolism*

Substances

  • CASP8 and FADD-Like Apoptosis Regulating Protein
  • CFLAR protein, human
  • FADD protein, human
  • Fas Ligand Protein
  • Fas-Associated Death Domain Protein
  • Multiprotein Complexes
  • Protein Isoforms
  • fas Receptor
  • Caspase 8